BEIJING, Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leadingChina-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009")
The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on March 3, 2010 (9:00 p.m. Beijing/Hong Kong time on March 3, 2010).
Conference Call The dial-in details for the live conference call are as follows: -- U.S. Toll Free Number 1-866-713-8562 -- International Dial-in Number 1-617-597-5310 Passcode: CMEDCALL
A live webcast of the conference call will be available on http://ir.chinameditech.com .
A replay of this webcast will be available for one month on this website.
A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on March 4, 2010. The dial-in details for the replay are as follows:
-- U.S. Toll Free Number 1-888-286-8010 -- International Dial-in Number 1-617-801-6888 Passcode: 33530003
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .
For more information, please contact: Winnie Yam Phone: +852-2511-9808 Email: IR@chinameditech.com
SOURCE China Medical Technologies, Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All